Japanese drug stocks get well on new products, M&A hopes

Article Abstract:

After lagging behind their foreign counterparts for many years, Japanese drug companies have experienced a turnaround. Firms such as Takeda Pharmaceutical and Ono Pharmaceuticals have new products ready to launch, stocks in the industry are soaring, and there is talk among investment bankers of a possible surge in mergers and acquisitions activity.

Japan, Acquisitions & mergers, Foreign operations, Securities issued, listed, Industry Overview, Foreign investments, Mergers, acquisitions and divestments, Company acquisition/merger, International aspects, Securities, Company securities, Foreign business enterprises

---

Glaxo signs biotech pacts in further deal making: Galapagos and Onco could reap payouts if new drugs deliver

Article Abstract:

GlaxoSmithKline PLC has signed agreements with US-based OncoMed Pharmaceuticals Inc. and Belgium's Galapagos N.V. for the biotechnology firms' product development in anti-cancer and anti-infective agents, respectively. Glaxo's upfront investment is limited; it will make further payments to OncoMed and Galapagos if products are successful.

Drugs, Alliances, partnerships, United Kingdom, Biotechnology industry, Biotechnology industries, Belgium, Cooperative agreement for product development, Alliances and partnerships, GlaxoSmithKline PLC, Galapagos Genomics N.V.

---

Novartis unit gets approval for copycat of biotech drug

Article Abstract:

Authorization for a generic copy of the growth hormone, Omnitrope has been granted by the European Commission to Sandoz. Sandoz is the generics unit of Novartis AG of Switzerland. The pharmaceutical company is also seeking permission for production of the medication from the United States Food and Drug Administration.

Europe, Switzerland, Government regulation, Novartis AG, Licensing, certification and accreditation, NVTSY, Omnitrope (Medication)

Similar abstracts:

• Abstracts: Vonage to sell Wi-Fi in EarthLink deal. Sony-Ericsson snags content for its online-music service. Motorola Inc. puts Macedonia on web
• Abstracts: Fears spread as Spanish real-estate stocks plunge: declines prompt worries that long building boom may soon come to a halt
• Abstracts: Suez, GDF offer new concessions to address EU fears about merger. Gaz de France net jumps; merger protests pick up
• Abstracts: GM's Wagoner takes control of ailing North American unit. GMAC reaps $8.8 billion from real-estate unit sale and large loan repayment
• Abstracts: Diamond group widens probe of bribe charges. President resigns from Gem Institute in scandal fallout

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.